Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ovarian Neoplasms
  Free Subscription

Articles published in
Int J Gynecol Pathol
    September 2025
  1. FALLAS J, Salmon I, Maris C, Gomez Galdon M, et al
    First Case of Ovarian Metastases From a Primary Retroperitoneal Mucinous Carcinoma Associated With Teratoma, With KRAS and ERBB3 Mutations: Case Report and Literature Review.
    Int J Gynecol Pathol. 2025;44:461-465.
    >> Share

  2. LEI L, Aisagbonhi O
    Sclerosis in Metastatic Uterine Tumor Resembling Ovarian Sex Cord Tumor: Diagnostic Dilemma Presented by Unusual Morphology.
    Int J Gynecol Pathol. 2025;44:457-460.
    >> Share

  3. GULSEREN V, Dolanbay M, Cagli F, Daggez M, et al
    The Role of hCG Expression in Endometrial Cancer Prognosis.
    Int J Gynecol Pathol. 2025;44:445-450.
    >> Share

  4. CHAPAGAIN U, Huecker JB, Sun L
    Morphologic Correlations With Homologous Recombination Deficiency in High-grade Serous Carcinomas.
    Int J Gynecol Pathol. 2025;44:398-406.
    >> Share

  5. LEPE M, Mejia E, Bu Y, Hecht JL, et al
    Morphologic Characteristics Seen in High-grade Serous Ovarian Carcinoma Metastases in Postneoadjuvant Chemotherapy Resections.
    Int J Gynecol Pathol. 2025;44:407-411.
    >> Share

    July 2025
  6. ZHAO T, Hung YP, Devins KM, Young RH, et al
    The Spectrum of Vascular Lesions of the Upper Female Genital Tract: A Report of 55 Cases.
    Int J Gynecol Pathol. 2025;44:291-307.
    >> Share

  7. ABBASI F, Nucci MR, Doron B, Ruskin R, et al
    Case Report: ESR1::CITED2 Fusion in a Malignant Uterine Tumor Resembling Ovarian Sex Cord Tumor.
    Int J Gynecol Pathol. 2025;44:368-373.
    >> Share

  8. NISHIJIMA Y, Inoue N, Iwase A, Ikota H, et al
    Lamin A and Emerin Protein Expression Remains Consistently Low and Nuclear Size is Unchanged in Normal Endometrium, Precancerous Lesions, and Endometrioid Carcinoma.
    Int J Gynecol Pathol. 2025;44:340-348.
    >> Share

  9. NEMEJCOVA K, Safanda A, Kendall Bartu M, Hajkova N, et al
    HER2 Status in Low-grade Serous Ovarian Tumors.
    Int J Gynecol Pathol. 2025;44:331-335.
    >> Share

    May 2025
  10. JO U
    Adenomatoid Tumor Mimicking Peritoneal Carcinomatosis: A Case Report.
    Int J Gynecol Pathol. 2025;44:286-290.
    >> Share

  11. CARLSON DK, Painter C, Gradecki SE, Ring KL, et al
    High-grade Endometrial Carcinomas With Solid Basaloid Morphology and Geographic Necrosis Lacking Definitive Pilomatrix-like Features: Clinicopathologic Characteristics Including Aggressive Behavior and Novel Molecular Events.
    Int J Gynecol Pathol. 2025;44:199-209.
    >> Share

  12. MASAADEH AH, Dundar B, Samuelson MI, Kadera E, et al
    Bilateral Somatically Derived Germ Cell Tumors With 12p Gains Arising in High-grade Serous Carcinomas of the Ovary: A Case Report and Review of the Literature.
    Int J Gynecol Pathol. 2025;44:258-264.
    >> Share

  13. YAMAGATA T, Watanabe K, Yamanoi K, Kakiuchi N, et al
    Origin of Peritoneal Cancer With Features of High-grade Serous Carcinoma: A Detailed Molecular Analysis.
    Int J Gynecol Pathol. 2025;44:280-285.
    >> Share

  14. GULSEREN V, Sen E, Dolanbay M, Cagli F, et al
    Association of Local and Distant Organ Metastases With MELF Pattern in Endometrial Cancer.
    Int J Gynecol Pathol. 2025;44:237-241.
    >> Share

  15. JAMES E, Ravikumar G, Michael Raj A J, Kulkarni K, et al
    Prognostic Significance of "High" Tumor Budding and "High" Poorly Differentiated Clusters in Endometrial Carcinomas: Independent Predictors of Lymphovascular Space Invasion and Lymph Node Metastasis.
    Int J Gynecol Pathol. 2025;44:222-229.
    >> Share

  16. YOO YJ, Kim YJ, Kim YM, Kim KR, et al
    The Prognostic Value of Tumor Cell Clusters in the Fallopian Tube Lumen in Stage I Endometrioid Carcinoma.
    Int J Gynecol Pathol. 2025;44:242-248.
    >> Share

    March 2025
  17. TURASHVILI G, Hanley K
    Malignant Brenner Tumor of the Ovary: A Critical Reappraisal.
    Int J Gynecol Pathol. 2025;44:182-192.
    >> Share

  18. MAHARJAN D, Collins K, Hou T, Umphress B, et al
    Synchronous Bilateral Ovarian Carcinomas With Right Mesonephric-like Adenocarcinoma and Left High-grade Serous Carcinoma: A Case Report and Review of the Literature.
    Int J Gynecol Pathol. 2025;44:193-197.
    >> Share

  19. LAWSON BC, Marques-Piubelli ML, Westin SN, Malpica A, et al
    Folate Receptor Immunohistochemical Staining and Gynecologic Tumors: Initial Experience With 216 Cases.
    Int J Gynecol Pathol. 2025;44:167-173.
    >> Share

  20. ZHAO X, Song Z, Liu Y, Zheng X, et al
    Synchronous Endometrial and Ovarian Endometrioid Carcinoma With MUTYH Germline Mutation: A Case Report With Genetic Analysis.
    Int J Gynecol Pathol. 2025;44:155-159.
    >> Share

    January 2025
  21. CHRISTENSEN D, Ghafoor M, Goldberg A, De Cotiis DA, et al
    Tumor Budding, Poorly Differentiated Clusters, and Stroma Percentage in Uterine Endometrioid Carcinomas Are Morphologic Findings Associated With Adverse Clinical Outcomes.
    Int J Gynecol Pathol. 2025;44:49-55.
    >> Share

  22. DEL MUNDO MM, Aguilar M, Chen H, Niu S, et al
    beta-catenin, PAX2, and PTEN Aberrancy Across the Spectrum of Endometrioid Ovarian Lesions.
    Int J Gynecol Pathol. 2025;44:79-87.
    >> Share

  23. DE BOECK A, Nohr E, El-Hallani S, Ghatage P, et al
    POLE-mutated Endometrial "Carcinosarcoma".
    Int J Gynecol Pathol. 2025;44:72-78.
    >> Share

  24. WANG L, Vasudevaraja V, Tran I, Sukhadia P, et al
    Novel Androgen Receptor Splice Variant 7 in Gynecologic Tumors.
    Int J Gynecol Pathol. 2025;44:88-93.
    >> Share

    November 2024
  25. DA-ANOY A, Kang EY, Lee CH, Cheasley D, et al
    Molecular Surrogate Subtypes of Ovarian and Peritoneal Low-grade Serous Carcinoma.
    Int J Gynecol Pathol. 2024;43:617-625.
    >> Share

  26. BUI CM, Azimpouran M, Balzer B, Maluf H, et al
    Stromal p16 and SATB2 Expression Does Not Distinguish Atypical Polypoid Adenomyoma (APA) From its Benign Mimics.
    Int J Gynecol Pathol. 2024;43:586-594.
    >> Share

  27. NOVIKOV FV, Anufriev AG, Efremov GD
    High-grade Serous Carcinoma Occurring in a Serous Cystadenoma on the Background of a Serous Tubal Intraepithelial Carcinoma (STIC)-like Lesion: A Case Report With Literature Review.
    Int J Gynecol Pathol. 2024;43:626-630.
    >> Share

  28. NAGY A, Niu N, Ratner E, Hui P, et al
    Novel FOXL2 Mutation in an Ovarian Adult Granulosa Cell Tumor: Report of a Case With Diagnostic and Clinicopathologic Implications.
    Int J Gynecol Pathol. 2024;43:631-636.
    >> Share

  29. FUKUMITSU C, Sanada S, Ogasawara S, Tsuda N, et al
    CXCR4 Expression and Cancer-associated Fibroblasts May Play an Important Role in the Invasion of Low-grade Endometrioid Carcinoma.
    Int J Gynecol Pathol. 2024;43:557-564.
    >> Share

  30. HACHISUGA K, Kawakami M, Tomonobe H, Maenohara S, et al
    Clinical Significance of Tumor Immune Microenvironment in Endometrial Endometrioid Carcinoma, Grade 1 With DNA Mismatch Repair Protein Loss.
    Int J Gynecol Pathol. 2024;43:573-585.
    >> Share

    September 2024
  31. VAZIRI FARD E, Imboden S, Rau T, Epstein E, et al
    p53 Abnormal (Copy Number High) Endometrioid Endometrial Carcinoma Has a Prognosis Indistinguishable From Serous Carcinoma.
    Int J Gynecol Pathol. 2024;43:515-526.
    >> Share

  32. MOH M, Puzyrenko A, Summey R, Rader JS, et al
    Clinicopathologic Characteristics of a Single-institution Cohort of Ovarian Adult Granulosa Cell Tumors, With Biomarker and Therapeutic Implications Utilizing the Detection of Androgen, Estrogen, and Progesterone Hormone Receptor Expression by Immunoh
    Int J Gynecol Pathol. 2024;43:527-534.
    >> Share

  33. HUVILA J, Jamieson A, Pors J, Hoang L, et al
    Endometrial Carcinosarcomas are Almost Exclusively of p53abn Molecular Subtype After Exclusion of Mimics.
    Int J Gynecol Pathol. 2024;43:506-514.
    >> Share

  34. LIU N, Lin W, Wang Y, Yao Z, et al
    Predicting Progestin Therapy Response With PTEN, PAX2, and beta-Catenin in Patients With Endometrioid Precancer.
    Int J Gynecol Pathol. 2024;43:494-505.
    >> Share

    July 2024
  35. MIYAMA Y, Ogasawara A, Hasegawa K, Yasuda M, et al
    Premature Classification of Early-stage Endometrioid Ovarian Carcinoma With Mesonephric-like Differentiation as Mesonephric-like Adenocarcinoma.
    Int J Gynecol Pathol. 2024;43:362-372.
    >> Share

  36. GILMORE B, Logan L, McKinnon W, Everett E, et al
    Endometrial Cancer in a Family With RAD51D Gene Mutation.
    Int J Gynecol Pathol. 2024;43:349-353.
    >> Share

  37. VIKI M, Morrow R
    Metastatic Hepatocellular Carcinoma Represents an Important but Rare Pitfall in the Diagnostic Evaluation of ER Negative Ovarian Malignancy: A Case Report.
    Int J Gynecol Pathol. 2024;43:378-381.
    >> Share

  38. ZHAO Z, Nadarajah R, Busmanis I
    Synchronous Bilateral Ovarian Mesonephric-like Adenocarcinomas with Separate Origins from High-Grade Mullerian Adenosarcoma and Endometriosis: Report of a Rare Case.
    Int J Gynecol Pathol. 2024;43:382-388.
    >> Share

  39. GUERRIERO A, Moro M, Angerilli V, Munari G, et al
    Synchronous Endometrial and Ovarian Carcinomas: Pathologic and Molecular Analysis Highlights the Monoclonal Origin of the Lesions.
    Int J Gynecol Pathol. 2024;43:309-315.
    >> Share

  40. WANG SC, Wu CH, Fu HC, Ou YC, et al
    Estrogen/Progesterone Receptor Expression and Cancer Antigen 125 Level as Preoperative Predictors to Estimate Lymph Node Metastasis in Endometrioid Endometrial Cancer.
    Int J Gynecol Pathol. 2024;43:316-325.
    >> Share

  41. AL-HUSSAINI M, McCluggage WG
    SATB2 Cytoplasmic Expression is Characteristic of a Subset of Ovarian Stromal Cells and Sex Cord Stromal Tumors.
    Int J Gynecol Pathol. 2024;43:373-377.
    >> Share

    June 2024
  42. WALIA A, Ladwig NR, Mak JS, Rabban JT, et al
    Prevalence of Occult Ovarian Cancer and Metastatic Breast Cancer in Ovarian Ablation Specimens of Patients With Hormone Receptor-Positive Breast Cancer: Implications for Tissue Sampling Strategies, Early Ovarian Cancer Detection and Resource Utilizati
    Int J Gynecol Pathol. 2024 Jun 26. doi: 10.1097/PGP.0000000000001055.
    >> Share

    May 2024
  43. ALROHAIBANI A, Yu Y, Gao L, McLean KM, et al
    PReferentially Expressed Antigen in MElanoma Expression in Uterine and Ovarian Carcinosarcomas.
    Int J Gynecol Pathol. 2024;43:284-289.
    >> Share

  44. YAMAMOTO A, Nagai T, Sukeda A, Kajiwara M, et al
    Ovarian Mesonephric-like Adenocarcinoma Recurring With a Rhabdomyosarcoma Component: A Case Report.
    Int J Gynecol Pathol. 2024;43:296-301.
    >> Share

  45. LI Y, Chen J, Niu S
    Endometrioid Adenocarcinoma With "Burrowing" Invasion of the Cervix Represents a Separate Primary From the Concurrent Uterine Corpus Endometrial Endometrioid Adenocarcinoma: Histology, Immunohistochemistry, and Next-generation Sequencing Study of a Si
    Int J Gynecol Pathol. 2024;43:271-274.
    >> Share

  46. XU J, Weisman PS
    Divergent Malignant Melanocytic Differentiation in Ovarian Endometrioid Adenocarcinoma With Aberrant beta-Catenin Expression: A Case Expanding the Histologic Spectrum of beta-Catenin Activated Gynecologic Neoplasia.
    Int J Gynecol Pathol. 2024;43:302-307.
    >> Share

  47. JU B, Wu J, Sun L, Yang C, et al
    Molecular Classification of Endometrial Endometrioid Carcinoma With Microcystic Elongated and Fragmented Pattern.
    Int J Gynecol Pathol. 2024;43:233-241.
    >> Share

  48. LEE Y, Choi S, Kim HS
    Comprehensive Immunohistochemical Analysis of Mesonephric Marker Expression in Low-grade Endometrial Endometrioid Carcinoma.
    Int J Gynecol Pathol. 2024;43:221-232.
    >> Share

    March 2024
  49. HAN R, Madariaga A, Gonzalez-Ochoa E, Smith AC, et al
    HER2-low and Overexpression in Mucinous Ovarian Cancer: Analysis of ASCO/CAP and ToGA Immunohistochemical Scoring.
    Int J Gynecol Pathol. 2024 Mar 4. doi: 10.1097/PGP.0000000000000972.
    >> Share

  50. XU J, McGregor SM, Park KJ, Weisman PS, et al
    Ovarian Endometrioid Adenocarcinomas With Infiltrative "Adenofibroma-like" Morphology and Aberrant ss-catenin Expression: Tumors That Coexpress CDX2 and LEF1 With Frequent Neuroendocrine Marker Expression, Diminished/Lost PAX8 and Possible Association
    Int J Gynecol Pathol. 2024;43:145-148.
    >> Share

  51. BHARDWAJ S, Banet N, Gaston EC
    Moderately-differentiated Ovarian Sertoli-Leydig Cell Tumor With a Concurrent Serous Borderline Tumor in a 16-year-old Girl.
    Int J Gynecol Pathol. 2024;43:140-144.
    >> Share

  52. SMITHGALL MC, Yemelyanova A, Mathew S, Gogineni S, et al
    HER2/ ERBB2 Immunohistochemical Expression and Copy Number Status in Ovarian Mucinous Tumors.
    Int J Gynecol Pathol. 2024;43:134-139.
    >> Share

  53. KENDALL BARTU M, Nemejcova K, Michalkova R, Bui QH, et al
    Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases.
    Int J Gynecol Pathol. 2024;43:123-133.
    >> Share

  54. KANG EY, Terzic T, Ghatage P, Woo L, et al
    TP53 as a Diagnostic Aid in the Distinction of Ovarian Mucinous Borderline Tumors From Mucinous Carcinoma.
    Int J Gynecol Pathol. 2024;43:111-122.
    >> Share

    January 2024
  55. FISCHER EG
    Two Rare Cases of Paratubal Leydig Cell Nodules: Clinical Relevance and Debated Terminology of a Noteworthy Incidentaloma.
    Int J Gynecol Pathol. 2024;43:97-101.
    >> Share

  56. ISE K, Tanei ZI, Oda Y, Tanikawa S, et al
    A Case of Uterine Tumor Resembling Ovarian Sex Cord Tumor With Prominent Myxoid Features.
    Int J Gynecol Pathol. 2024;43:41-46.
    >> Share

  57. WESSMAN S, Fuentes BB, Severin-Karlsson J, Westbom-Fremer S, et al
    FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology.
    Int J Gynecol Pathol. 2024;43:78-89.
    >> Share

  58. KAWAGUCHI R, Maehana T, Sugimoto S, Kawahara N, et al
    Immunohistochemical Analysis of the Tissue Factor Pathway Inhibitor-2 in Endometrial Clear Cell Carcinoma: A Single-center Retrospective Study.
    Int J Gynecol Pathol. 2024;43:25-32.
    >> Share

  59. XU J, Park KJ, Weisman PS
    An Expanded Series of Pilomatrix-like High-grade Endometrioid Carcinoma (PiMHEC), Including Both MMR Deficient and MMR Proficient Cases.
    Int J Gynecol Pathol. 2024;43:67-69.
    >> Share

  60. ELMUTI L, Amundson J, Oberman E, Kamat A, et al
    Diffuse Pediatric-type High-grade Glioma Arising in an Ovarian Mature Cystic Teratoma.
    Int J Gynecol Pathol. 2024;43:90-96.
    >> Share

  61. WEPY C, Nucci MR, Parra-Herran C
    Atypical Endometriosis: Comprehensive Characterization of Clinicopathologic, Immunohistochemical, and Molecular Features.
    Int J Gynecol Pathol. 2024;43:70-77.
    >> Share

    November 2023
  62. YOSHINO Y, Yanai S, Sawada M, Sakate S, et al
    Extraovarian Dysgerminoma Involving the Uterine Cervix: A Rare Case Report With Literature Review.
    Int J Gynecol Pathol. 2023;42:544-549.
    >> Share

  63. MATSUMOTO N, Manrai P, Rottmann D, Wu X, et al
    Correlative Assessment of p53 Immunostaining Patterns and TP53 Mutation Status by Next-Generation Sequencing in High-Grade Endometrial Carcinomas.
    Int J Gynecol Pathol. 2023;42:567-575.
    >> Share

  64. ALNA'IRAT M, McCluggage WG, Al-Hussaini M
    Ovarian Immature Teratoma With Nodal Gliomatosis: A Case Report and Literature Review.
    Int J Gynecol Pathol. 2023;42:627-631.
    >> Share

  65. STOLNICU S, Bartalis RJ, Ye Q, Da Cruz Paula A, et al
    Ovarian RASoma With Mesonephric-like Adenocarcinoma and Mixed Mullerian Components: A Case Report With Molecular Analysis Demonstrating Multidirectional Mullerian Differentiation.
    Int J Gynecol Pathol. 2023;42:620-626.
    >> Share

  66. LIN LH, Zamuco RD, Shukla PS
    Ovarian Clear Cell Carcinoma and Markers of Epithelial-Mesenchymal Transition (EMT): Immunohistochemical Characterization of Tumor Budding.
    Int J Gynecol Pathol. 2023;42:602-612.
    >> Share

    October 2023
  67. BICER E, Bese T, Tuzun DD, Ilvan S, et al
    The Relationship Between Melatonin 1-2 Receptor Expression in Patients With Epithelial Ovarian Cancer and Survival.
    Int J Gynecol Pathol. 2023 Oct 4. doi: 10.1097/PGP.0000000000000968.
    >> Share

    September 2023
  68. KEANE E, Floyd R, McDonnell C, Beirne JP, et al
    Endometrioid Adenocarcinoma Resembling Cutaneous Pilomatrix Carcinoma: A Case Report of an Aggressive Neoplasm in a Young Woman With Diffusely Aberrant Beta-catenin Expression and Associated Morular Metaplasia and Atypical Polypoid Adenomyoma-type Cha
    Int J Gynecol Pathol. 2023;42:466-471.
    >> Share

  69. DYHDALO KS, Ababneh E, Lanigan C, Bowers K, et al
    Evaluation of Lineage/Site-specific Nuclear Immunohistochemical Markers SATB2, Cyclin D1, SALL4, and BCOR in High-grade Endometrial Carcinomas.
    Int J Gynecol Pathol. 2023;42:443-450.
    >> Share

  70. KEYHANIAN K, Yang EJ, Howitt BE
    Nuclear beta-Catenin Expression in the Context of Abnormal p53 Expression Indicates a Nonserous Histotype in Endometrial Carcinoma.
    Int J Gynecol Pathol. 2023;42:435-442.
    >> Share

  71. TALIA KL, Ratnayake G, McCluggage WG
    Microscopic Sertoliform Sex Cord Proliferation Involving Pelvic Peritoneum: Report of a Case Associated With Endosalpingiosis.
    Int J Gynecol Pathol. 2023;42:496-499.
    >> Share

  72. DONTHI D, Chen H, Peng Y, Niu S, et al
    Ovarian Microcystic Stromal Tumor With Intraovarian Recurrence and Peritoneal and Omental Spread: A Case Report With Morphological, Immunohistochemical, and Molecular Analysis.
    Int J Gynecol Pathol. 2023;42:491-495.
    >> Share

  73. CHIESA-VOTTERO AG
    Ovarian Mucinous Borderline Tumor With Intraepithelial Carcinoma.
    Int J Gynecol Pathol. 2023;42:514.
    >> Share

  74. GUERRIERI C, Hudacko R, Anderson P
    Composite FOXL2 Mutation-positive Adult Granulosa Cell Tumor and Serous Borderline Tumor of the Ovary.
    Int J Gynecol Pathol. 2023;42:500-507.
    >> Share

  75. CHUI MH, Murali R, Soslow RA, Matrai C, et al
    Interobserver Reproducibility in Assessing Eosinophilic Cells in Ovarian Serous Borderline Tumors to Predict BRAF Mutational Status.
    Int J Gynecol Pathol. 2023;42:472-481.
    >> Share

  76. ANDRADE LALA, Alame M, Truffaux N, Croce S, et al
    Adult Granulosa Cell Tumour With Heterologous Adipocytic Differentiation: Report of a Unique Case.
    Int J Gynecol Pathol. 2023;42:508-513.
    >> Share

    July 2023
  77. CHUI MH, Grisham RN
    Somatic BAP1 Loss in Ovarian Serous Borderline Tumor and Recurrent Low-grade Serous Carcinoma From a Germline BAP1 Mutation Carrier.
    Int J Gynecol Pathol. 2023;42:432-433.
    >> Share

  78. TALHOUK A, Jamieson A, Crosbie EJ, Taylor A, et al
    Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol.
    Int J Gynecol Pathol. 2023;42:353-363.
    >> Share

  79. BRAUN A, Reddy S, Cheng L, Gattuso P, et al
    Clinicopathologic Review of Metastatic Breast Cancer to the Gynecologic Tract.
    Int J Gynecol Pathol. 2023;42:414-420.
    >> Share

  80. HALL KC, Post MD, Alldredge J, Aisner DL, et al
    Molecular Evidence for Epithelial Origin of Mixed Ovarian Epithelial-Germ Cell Neoplasms: Report of 2 Cases and Review of Literature.
    Int J Gynecol Pathol. 2023;42:403-413.
    >> Share

  81. KOSTELECKY N, Ozhegov E, Cao D, Krigman H, et al
    Metastatic Cholangiocarcinoma to the Uterus Morphologically Imitating Primary Intestinal-type Endometrioid Adenocarcinoma.
    Int J Gynecol Pathol. 2023;42:398-402.
    >> Share

  82. LAU JCC, McCluggage WG, Yuen LYP, Shing MMK, et al
    DICER1 -Altered Extraovarian Moderately Differentiated Sertoli-Leydig Cell Tumor: Report of a Rare Case.
    Int J Gynecol Pathol. 2023;42:421-425.
    >> Share

  83. SUN Y, Liu-Jarin X, Hamele-Bena D, Murty VV, et al
    Ovarian Malignant Mixed Germ Cell Tumor With Prominent Embryoid Bodies (Polyembryoma Background): A Case Report and Literature Review.
    Int J Gynecol Pathol. 2023;42:426-431.
    >> Share

    May 2023
  84. STRICKLAND AL, Maniar KP, Tanner E, Shanes E, et al
    Borderline With Bad Behavior: An Unusual Low-grade Serous Carcinoma With Dedifferentiation From a Serous Borderline Tumor.
    Int J Gynecol Pathol. 2023;42:241-246.
    >> Share

  85. YOSHIDA H, Uno M, Ogimoto K, Kobayashi-Kato M, et al
    Endometrioid Endometrial Carcinoma With NKX3.1 Expression in a Transgender Man: A Case Report.
    Int J Gynecol Pathol. 2023;42:308-314.
    >> Share

  86. OMO-OGBOI AC, Deavers MT, Schmeler KM, Tandon N, et al
    Collision Tumor of the Ovary Involving Sertoli-Leydig Cell Tumor and High-Grade Serous Carcinoma-Report of the First Case.
    Int J Gynecol Pathol. 2023;42:254-258.
    >> Share

  87. MENDOZA R, Kertowidjojo E
    CTNNB1 -mutated High-grade Endometrioid Carcinoma With Extensive Squamous and Shadow Cell Differentiation Can Mimic Pilomatrix Carcinoma.
    Int J Gynecol Pathol. 2023;42:325-326.
    >> Share

  88. HALLING GC, Udager AM, Skala SL
    Endometrial, Ovarian, and Peritoneal Involvement by Endometrioid Carcinoma, Yolk Sac Tumor, and Endometriosis: Molecular Evidence for a Shared Precursor.
    Int J Gynecol Pathol. 2023;42:247-253.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016